Aura Biosciences, Inc.

AURA · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$26-$27-$27-$26
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$4$4$4$3
Change in WC$2$2$0-$1
Other Non-Cash$0$0-$0-$0
Operating Cash Flow-$20-$21-$23-$24
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$74-$10$0-$0
Inv. Sales/Matur.$30$30$30$30
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$44$20$30$30
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$3$70$0$1
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1$0$0$0
Financing Cash Flow$4$70$0$1
Forex Effect-$0$0-$0$0
Net Chg. in Cash-$60$69$7$6
Supplemental Information
Beg. Cash$108$39$32$26
End Cash$48$108$39$32
Free Cash Flow-$20-$21-$24-$24
Aura Biosciences, Inc. (AURA) Financial Statements & Key Stats | AlphaPilot